Strumento inattivo

Azioni Medarex inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

MEDAREX : After Medarex buy, biotech investors ask who's next	23/07/09
MEDAREX : to Host Clinical Program Update Conference Call on Tuesday, June 2, 2009	26/05/09
MEDAREX : to Present at the Bank of America and Merrill Lynch Health Care Conference	05/05/09
MEDAREX : to Host Business and Financial Update Conference Call on Thursday, April 30, 2009	29/04/09
MEDAREX : to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis	14/04/09

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	+6,96%	101 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+8,29%	42,63 Mrd
BIOGEN INC.	-11,09%	33,5 Mrd
UCB	+82,32%	29,77 Mrd
BIOMARIN PHARMACEUTICAL INC.	-11,82%	16,14 Mrd
INCYTE CORPORATION	+1,39%	14,31 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,13%	11,55 Mrd
ALTEOGEN INC.	+176,65%	10,53 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+6,74%	9,2 Mrd